Loading
Zeria Pharmaceutical
Zeria is a Tokyo pharmaceutical company founded in 1955, strongest in gastroenterology, that sponsors phase 3 cancer trials in Japan.
Also called: Zeria Pharmaceutical Co., Ltd.ゼリア新薬工業
Overview
Zeria Pharmaceutical Co., Ltd., based in Chūō, Tokyo, and founded in 1955, makes prescription and consumer medicines with a focus on gastrointestinal disease, including bowel preparations used before colonoscopy, and has acted as lead sponsor of phase 3 trials in cancer-related settings registered on ClinicalTrials.gov.
Connected
4Similar pages
- CompanyNorgine
Shares Colorectal cancer screening (colonoscopy, FIT, stool DNA, blood), Pivotal (registrational) trial, Clinical trial, Colorectal cancer.
- CompanyMast Therapeutics
Shares Pivotal (registrational) trial, Clinical trial, Colorectal cancer.
- CompanyPregLem
- CompanyAgennix
- CompanyLisata Therapeutics
- CompanyImmunitor
- CompanyEmergent BioSolutions
- CompanyHarbour BioMed
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
ClinicalTrials.gov · 1
wikidata.org · 1
zeria.co.jp · 1
A source that has moved or gone is reported by the weekly link check. /audit/